The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial
Published Online: 2023-11-17
Journal: Nature MedicineLoading...
Authors: Andrea T. Franson•Angela J. Waanders•Ashley Walter•Cassie Kline•Daniel Da Costa•Daniel Landi•Darren Hargrave•David S. Ziegler•Devorah Segal•Dong-Anh Khuong-Quang•Enrica E. K. Tan•Geoffrey McCowage•Helen Toledano•Hyoung Jin Kang•Izzy Cornelio•Jasper van der Lugt•Jordan R. Hansford•Jung Woo Han•Karsten Nysom•Liat Oren•Lindsay B. Kilburn•Lisa McLeod•Michal Yalon Oren•Mohamed S. Abdelbaki•Nada Jabado•Nicholas G. Gottardo•Nicholas S. Whipple•Nicolas U. Gerber•Olaf Witt•Pablo Hernáiz Driever•Patricia A. Baxter•Peter Manley•Roger J. Packer•Sabine Mueller•Samuel C. Blackman•Sarah E. S. Leary•Simon Bailey•Susan N. Chi•Sébastien Perreault•Timothy E. Hassall•Valérie Larouche•Xin Zhao
